FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
WASHINGTON (AP) — The Food and Drug Administration said Friday it will add a new warning and other limitations to a gene therapy for Duchenne's muscular dystrophy that's been linked to two patient deaths. The infused therapy from Sarepta Therapeutics will car
(Financial Post, 2025-11-14T20:18:19Z)